Doctor profile · Federal record
Dr. TIMOTHY BOOKER, PA-C
Physician Assistant · Medical Physician Assistant · LITTLE ROCK, AR
- NPI 1538494091
- Accepts Medicare
- 27 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
9601 BAPTIST HEALTH DR, SUITE 800
LITTLE ROCK, AR 722056321
(501) 227-0421 - Mailing address
-
9404 BUCK HAVEN TRL
TALLAHASSEE, FL 323124101
Credentials & registration
- NPI registered
- October 2009 — 17 yrs on file
- Profile last updated
- February 3, 2017
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State licenses (2)
- Arkansas #PA 672 · Florida #PA9101219
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1538494091. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
580
Distinct HCPCS
3
Medicare allowed
$48,415
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 425 | 234 | $70 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 111 | 111 | $127 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 44 | 44 | $100 |
In context: peer comparison
Among 38 peers in this city , average services per provider: 453. This provider delivers 1.3× the peer median.Open Payments
Industry payments received
All-time total
$2,541
Transactions
121
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 31 | $662.65 | |
| Novartis Pharmaceuticals Corporation | 22 | $408.05 | |
| SK Life Science, Inc. | 10 | $207.09 | |
| PFIZER INC. | 14 | $185.91 | |
| MDD US Operations, LLC | 4 | $151.86 | |
| ACADIA Pharmaceuticals Inc | 7 | $150.94 | |
| UCB, Inc. | 7 | $111.18 | |
| Neurocrine Biosciences, Inc. | 5 | $88.66 | |
| Lundbeck LLC | 4 | $84.90 | |
| Biogen, Inc. | 4 | $73.98 | |
| Lilly USA, LLC | 4 | $59.64 | |
| LivaNova USA, Inc. | 2 | $54.84 | |
| Otsuka America Pharmaceutical, Inc. | 3 | $43.81 | |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | 2 | $39.31 | |
| CATALYST PHARMACEUTICALS, INC. | 2 | $32.96 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,537
Patients
275
Total drug cost
$291,152
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Memantine Hcl | Generic | 210 | 43 | $4,501 |
| Carbidopa-Levodopa (Carbidopa/Levodopa) | Brand | 203 | 37 | $5,049 |
| Levetiracetam | Generic | 173 | 29 | $4,808 |
| Gabapentin | Generic | 162 | 31 | $4,275 |
| Emgality Pen (Galcanezumab-Gnlm) | Brand | 112 | 20 | $107,899 |
| Donepezil Hcl | Generic | 109 | 25 | $1,132 |
| Primidone | Generic | 96 | 20 | $2,425 |
| Topiramate | Generic | 79 | 19 | $991 |
| Rytary (Carbidopa/Levodopa) | Brand | 70 | 11 | $88,729 |
| Pregabalin | Generic | 69 | 13 | $1,648 |